"Amantadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
Descriptor ID |
D000547
|
MeSH Number(s) |
D02.455.426.100.050.035
|
Concept/Terms |
Amantadine- Amantadine
- 1-Aminoadamantane
- 1 Aminoadamantane
- Adamantylamine
Amanta-Sulfate-AZU- Amanta-Sulfate-AZU
- Amanta Sulfate AZU
- AmantaSulfateAZU
- Amantadin AZU
- AZU, Amantadin
|
Below are MeSH descriptors whose meaning is more general than "Amantadine".
Below are MeSH descriptors whose meaning is more specific than "Amantadine".
This graph shows the total number of publications written about "Amantadine" by people in this website by year, and whether "Amantadine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 3 | 1 | 4 |
2018 | 2 | 1 | 3 |
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Amantadine" by people in Profiles.
-
Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses. 2021 03 24; 13(4).
-
[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection]. Pol Merkur Lekarski. 2021 Feb 24; 49(289):67-70.
-
Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2. Pharmacol Rep. 2021 Jun; 73(3):962-965.
-
[Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova. 2021; 121(4):101-106.
-
Amantadine for COVID-19. J Clin Pharmacol. 2021 03; 61(3):412-413.
-
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics. Front Cell Infect Microbiol. 2020; 10:589505.
-
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat Struct Mol Biol. 2020 12; 27(12):1202-1208.
-
Observational study of people infected with SARS-Cov-2, treated with amantadine. Pharmacol Rep. 2020 Dec; 72(6):1538-1541.
-
SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine. Rom J Morphol Embryol. 2020 Oct-Dec; 61(4):1007-1022.
-
Response to: Amantadine, COVID-19 and Parkinsonism. Arch Med Res. 2020 10; 51(7):715.